K200047 is an FDA 510(k) clearance for the ExcelsiusGPS Cranial 1.0 Module. Classified as Orthopedic Stereotaxic Instrument within the OLO classification (a category covering orthopedic stereotaxic and surgical navigation instruments), Class II - Special Controls.
Submitted by Globus Medical, Inc. (Audubon, US). The FDA issued a Cleared decision on July 10, 2020 after a review of 183 days - an extended review cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.
View all Globus Medical, Inc. devices